 LAWRENCEVILLE, N.J., Sept. 07, 2022 GLOBE NEWSWIRE -- Celsion Corporation NASDAQ: CLSN, a clinical-stage drug development company today announced that Dr. Corinne Le Goff, President and Chief Executive Officer will present a company overview and be available for 1x1 meetings at the upcoming H.C. Wainwright 24th Annual Global Investment Conference. The hybrid conference will be held from September 12-14 with in-person participation held at the Lotte New York Palace Hotel. 